Search results for "Photosensitizing agents"

showing 10 items of 66 documents

New tricyclic systems as photosensitizers towards triple negative breast cancer cells.

2022

AbstractNineteen pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones were synthesized as new tricyclic systems in which the pyridine ring is annelated to the 6,7-dihydroindolizin-8(5H)-one and 5,6,7,8-tetrahydro-9H-pyrrole[1,2-a]azepine-9-one moieties to obtain potential photosensitizing agents. They were tested for their photoantiproliferative activity on a triple-negative breast cancer cell line, MDA-MB-231, in the dark and under UVA light (2.0 J/cm2). We demonstrated that their toxicity, only when exposed to light, was primarily due to the generation of reactive oxygen species while their photodegradation products were not responsible for their activity. The mos…

7]naphthyridinonePhotosensitizing AgentsPyrrolo[12-h][17]naphthyridinoneCell DeathMDA-MB-231Organic ChemistryPhototoxic activityTriple Negative Breast NeoplasmsApoptosisPyrido[23-c]pyrrolo[12-a]azepinoneTriple-negative breast cancerPyrrolo[1Drug DiscoveryMolecular MedicineHumans2-h][1Pyrido[23-c]pyrrolo[12-a]azepinoneMDA-MB-231; Photosensitizing agents; Phototoxic activity; Pyrido[23-c]pyrrolo[12-a]azepinone; Pyrrolo[12-h][17]naphthyridinone; Triple-negative breast cancerReactive Oxygen SpeciesArchives of pharmacal research
researchProduct

DNA damage photo-induced by chloroharmine isomers: hydrolysis versus oxidation of nucleobases

2018

Photodynamic therapy (PDT) is an emerging clinical treatment currently being used against a wide range of both cancerous and noncancerous diseases. The search for new active photosensitizers as well as the development of novel selective delivery systems are the major challenges faced in the application of PDT. We investigated herein three chloroharmine derivatives (6-, 8- and 6,8-dichloroharmines) with quite promising intrinsic photochemical tunable properties and their ability to photoinduce DNA damage in order to elucidate the underlying photochemical mechanisms. Data revealed that the three compounds are quite efficient photosensitizers. The overall extent of photo-oxidative DNA damage i…

DNA damagemedicine.medical_treatmentSubstituentPhotodynamic therapyAntineoplastic Agents010402 general chemistryRing (chemistry)01 natural sciencesBiochemistryNucleobase//purl.org/becyt/ford/1 [https]Hydrolysischemistry.chemical_compoundIsomerism//purl.org/becyt/ford/1.4 [https]medicineDNA Breaks Single-StrandedPhysical and Theoretical ChemistryPurine metabolismClinical treatmentPhotosensitizing Agents010405 organic chemistryHydrolysisOrganic ChemistryCiencias QuímicasCombinatorial chemistry0104 chemical sciencesHarmineQuímica OrgánicachemistryPhotochemotherapyβ-CarbolinesDNA damageChlorineOxidation-ReductionCIENCIAS NATURALES Y EXACTASDNA Damage
researchProduct

Synergistic Anticancer Therapy by Ovalbumin Encapsulation-Enabled Tandem Reactive Oxygen Species Generation

2020

Abstract The anticancer efficacy of photodynamic therapy (PDT) is limited due to the hypoxic features of solid tumors. We report synergistic PDT/chemotherapy with integrated tandem Fenton reactions mediated by ovalbumin encapsulation for improved in vivo anticancer therapy via an enhanced reactive oxygen species (ROS) generation mechanism. O2 .− produced by the PDT is converted to H2O2 by superoxide dismutase, followed by the transformation of H2O2 to the highly toxic .OH via Fenton reactions by Fe2+ originating from the dissolution of co‐loaded Fe3O4 nanoparticles. The PDT process further facilitates the endosomal/lysosomal escape of the active agents and enhances their intracellular deliv…

inorganic chemicalsNanomedicines | Hot PaperOvalbuminmedicine.medical_treatmentRadicalsynergisticcisplatinPhotodynamic therapyAntineoplastic Agents010402 general chemistry01 natural sciencesCatalysisSuperoxide dismutasechemistry.chemical_compoundMicemedicineAnimalsHumansResearch Articleschemistry.chemical_classificationCisplatinReactive oxygen speciesOxidase testPhotosensitizing Agentsbiology010405 organic chemistryFenton reactionsDrug SynergismGeneral MedicineGeneral ChemistryhypoxicEndocytosis0104 chemical sciencesOvalbuminchemistryphotodynamic therapybiology.proteinBiophysicsMCF-7 CellsReactive Oxygen SpeciesNicotinamide adenine dinucleotide phosphatemedicine.drugResearch Article
researchProduct

Progress of Phototherapy Applications in the Treatment of Bone Cancer

2021

Bone cancer including primary bone cancer and metastatic bone cancer, remains a challenge claiming millions of lives and affecting the life quality of survivors. Conventional treatments of bone cancer include wide surgical resection, radiotherapy, and chemotherapy. However, some bone cancer cells may remain or recur in the local area after resection, some are highly resistant to chemotherapy, and some are insensitive to radiotherapy. Phototherapy (PT) including photodynamic therapy (PDT) and photothermal therapy (PTT), is a clinically approved, minimally invasive, and highly selective treatment, and has been widely reported for cancer therapy. Under the irradiation of light of a specific wa…

Oncologymedicine.medical_specialtyQH301-705.5Photothermal Therapymedicine.medical_treatmentCancer therapyBone NeoplasmsPhotodynamic therapyReviewCatalysisInorganic ChemistryInternal medicineHumansMedicineBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyOsteosarcomaChemotherapyPhotosensitizing Agentsbusiness.industryBone cancerOrganic ChemistryCancerbone cancerGeneral MedicinePhototherapyPhotothermal therapymedicine.diseaseComputer Science ApplicationsRadiation therapyChemistryPrimary bonephotodynamic therapyPhotochemotherapyNanoparticlesGoldtumor therapyNeoplasm Recurrence LocalReactive Oxygen SpeciesbusinessInternational Journal of Molecular Sciences
researchProduct

A novel pro-apoptotic role of zinc octacarboxyphthalocyanine in melanoma me45 cancer cell's photodynamic therapy (PDT)

2018

Abstract Zn-based phthalocyanine acts as drug or photosensitizer in photodynamic therapy (PDT) for the treatment of cancer cells. The activated zinc octacarboxyphthalocyanine (ZnPcOC) reacts with oxygen, to generate reactive oxygen species for the damage of melanoma cancer cells, Me45. This in vitro study aimed at investigating the cytotoxic effects of different concentrations of ZnPcOC activated with a diode laser (λ = 685 nm) on Me45, and normal human fibroblast cells, NHDF. To perform this study 104 cells/ml were seeded in 96-well plates and allowed to attach overnight, after which cells were treated with different concentrations of ZnPcOC (10, 20 and 30 μM). After 4 h, cells were irradi…

Programmed cell deathIndolesCell Survivalmedicine.medical_treatmentPhotodynamic therapy (PDT)030303 biophysicsBiophysicsApoptosisPhotodynamic therapy02 engineering and technologyIsoindolesZinc octacarboxyphthalocyanine (ZnPcOC)PhotosensitizersCell Line03 medical and health sciencesCell Line TumorOrganometallic CompoundsmedicineHumansCytotoxic T cellRadiology Nuclear Medicine and imagingPhotosensitizerViability assayMelanoma0303 health sciencesPhotosensitizing AgentsRadiationRadiological and Ultrasound TechnologyChemistryMelanomaReactive oxygen species (ROS)UV–Vis spectraFibroblasts021001 nanoscience & nanotechnologymedicine.diseasePhotochemotherapyZinc CompoundsApoptosisCancer cellCancer researchMelanoma Me45 cancer cellsLasers SemiconductorPro-apoptotic activityReactive Oxygen Species0210 nano-technologyJournal of Photochemistry and Photobiology B-Biology
researchProduct

THIOPYRANO[2,3-E]INDOL-2-ONES: ANGELICIN HETEROANALOGUES WITH POTENT PHOTOANTIPROLIFERATIVE ACTIVITY

2008

A new class of compounds, the thiopyrano[2,3-e]indol-2-ones, bioisosters of the angular furocoumarin angelicin, was synthesized with the aim of obtaining new photochemotherapeutic agents. In particular 7,8-dimethyl-thiopyranoindolone 6c s showed a remarkable phototoxicity and a great dose UVA dependence reaching IC(50) values at submicromolar level. This latter photoinduced a massive apoptosis and a remarkable photodamage to lipids and proteins. Although it did not intercalate DNA, it was able to cause photooxidation of DNA bases.

IndolesStereochemistryDNA damageUltraviolet RaysAngelicinThiopyrano[23-e ]indol-2-oneClinical BiochemistryPharmaceutical ScienceHL-60 CellsApoptosisThiopyrano[2Antiproliferative activityBiochemistryChemical synthesischemistry.chemical_compoundInhibitory Concentration 50Jurkat CellsAngelicinPhotochemotherapeutic agentsFurocoumarinsDrug DiscoveryThiolactoneTumor Cells CulturedHumansPhotosensitizer3-e ]indol-2-onesMolecular BiologyPhotosensitizing AgentsFurocoumarinOrganic ChemistryProteinsBiological activityThiopyrano[2; 3-e ]indol-2-ones; Angelicin; Antiproliferative activity; Photochemotherapeutic agents; ApoptosisDNASettore CHIM/08 - Chimica FarmaceuticaMitochondriachemistryPhotochemotherapeutic agentMolecular MedicineLipid PeroxidationPhototoxicityDNA Damage
researchProduct

Back pain after photodynamic therapy with verteporfin.

2005

Purpose To report the incidence of back pain after photodynamic therapy, which suggests methods for prevention that are related to its pathogenesis. Design Retrospective case series. Methods We retrospectively observed 548 patients who had undergone photodynamic therapy with verteporfin. Results Of 548 patients at the first treatment, 14 patients (2.6%) experienced pain during the infusion. Eleven patients were being treated for age-related macular degeneration; their mean age was 81 years, which significantly differed from the mean age of the overall age-related macular degeneration group ( P = .003). The pain was mild in eight patients, moderate in four patients, and severe in two patient…

Malemedicine.medical_specialtyPorphyrinsmedicine.medical_treatmentPhotodynamic therapyMacular Degenerationback painphotodynamic therapymedicineBack painHumansInfusions IntravenousAgedRetrospective StudiesAged 80 and overPhotosensitizing AgentsMild painSettore MED/30 - Malattie Apparato Visivobusiness.industryIncidence (epidemiology)IncidenceVerteporfinRetrospective cohort studyMacular degenerationMiddle Agedmedicine.diseaseVerteporfinLow back painChoroidal NeovascularizationSurgeryOphthalmologyPhotochemotherapyBack PainMyopia DegenerativeFemalemedicine.symptombusinessmedicine.drugAmerican journal of ophthalmology
researchProduct

Hypoxia-Selective Dissociation Mechanism of a Nitroimidazole Nucleoside in a DNA Environment

2019

Photodynamic therapy is a promising approach to treat a variety of superficial tumors and other diseases. One of its major limitations arises from its dependence on molecular oxygen, which decreases the efficiency of the therapy in hypoxia conditions commonly developed by solid tumors. The present contribution reveals the molecular mechanism of a modified thymine bearing a nitroimidazole substituent, a photosensitizer able to produce highly harmful interstrand cross-links in the DNA double strand after irradiation selectively in absence of oxygen. The mechanism is resolved at a fully atomistic and electronic level relying on quantum mechanics (CASPT2, coupled-cluster, DFT, and TD-DFT method…

SubstituentMolecular Dynamics Simulation010402 general chemistry01 natural scienceschemistry.chemical_compoundMolecular dynamics[CHIM]Chemical SciencesGeneral Materials SciencePhotosensitizerA-DNAPhysical and Theoretical ChemistryComputingMilieux_MISCELLANEOUSPhotosensitizing AgentsNitroimidazole010405 organic chemistryHydrogen bondHydrogen BondingDNA0104 chemical sciencesThyminechemistryNitroimidazolesBiophysicsNucleic Acid ConformationQuantum TheoryDNAThe Journal of Physical Chemistry Letters
researchProduct

Oxidative DNA damage and mutations induced by a polar photosensitizer, Ro19-8022.

1999

The oxidative DNA damage induced by the polar photosensitizer Ro19-8022 in the presence of light was studied and correlated with the associated mutagenicity. Both in isolated DNA and AS52 Chinese hamster ovary cells, photoexcited Ro19-8022 gave rise to a DNA damage profile that was similar to that caused by singlet oxygen: base modifications sensitive to the repair endonuclease Fpg protein, which according to high-performance liquid chromatography (HPLC) analysis were predominantly 8-hydroxyguanine (8-oxoG) residues, were generated in much higher yield than single-strand breaks, sites of base loss (AP sites) and oxidative pyrimidine modifications sensitive to endonuclease III. Fifty percent…

PyrrolidinesDNA damageMolecular Sequence DataCHO CellsBiologyToxicologymedicine.disease_causechemistry.chemical_compoundPlasmidCricetinaeGeneticsmedicineAnimalsPhotosensitizerMutation frequencyMolecular BiologyGenePhotosensitizing AgentsBase SequenceCell-Free SystemChinese hamster ovary cellOxidative StressBiochemistrychemistryDNA ViralMutationDNAOxidative stressQuinolizinesDNA DamageMutation research
researchProduct

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment

2003

The effects of combined and simultaneously applied localised 43 degrees C hyperthermia (HT) and an antivascular bacteriochlorophyll-serine-based photodynamic therapy (Bchl-ser-PDT) on tumour growth and several microenvironmental parameters were examined. Rats bearing DS-sarcomas were allocated to treatment groups: (i) sham-treatment (control), (ii) Bchl-ser-PDT (20 mg kg(-1) i.v.), (iii) localised HT, (iv) Bchl-ser-PDT+HT. The light source used was an infrared-A irradiator, which, by use of appropriate filters, delivered the different ranges of wavelengths required. Following treatment, tumour volume was monitored. The greatest tumour growth inhibition was seen with Bchl-ser-PDT+HT, and sub…

MaleHyperthermiaCancer ResearchPathologymedicine.medical_specialtymedicine.medical_treatmentAngiogenesis InhibitorsPhotodynamic therapyOxidative phosphorylationBiologyPharmacologyRats Sprague-DawleyNeovascularizationchemistry.chemical_compoundmedicineAnimalsblood flowCombined Modality TherapyGlycolysisExperimental TherapeuticBacteriochlorophyllsPhotosensitizing AgentsNeovascularization PathologicbacteriochlorophyllHyperthermia InducedOxygenationhyperthermiamedicine.diseaseCombined Modality TherapyCell Hypoxiametabolic statusRatsPhotochemotherapyphotodynamic therapyOncologychemistryModels AnimalSarcoma ExperimentaloxygenationGrowth inhibitionmedicine.symptomCell DivisionBritish Journal of Cancer
researchProduct